VACCINE PROPHYLAXIS OF Q-FEVER - A FOLLOW-UP-STUDY OF THE EFFICACY OFQ-VAX (CSL) 1985-1990

Citation
Jr. Ackland et al., VACCINE PROPHYLAXIS OF Q-FEVER - A FOLLOW-UP-STUDY OF THE EFFICACY OFQ-VAX (CSL) 1985-1990, Medical journal of Australia, 160(11), 1994, pp. 704-708
Citations number
14
Categorie Soggetti
Medicine, General & Internal
ISSN journal
0025729X
Volume
160
Issue
11
Year of publication
1994
Pages
704 - 708
Database
ISI
SICI code
0025-729X(1994)160:11<704:VPOQ-A>2.0.ZU;2-N
Abstract
Objectives: To examine the efficacy of various batches of a formalin-i nactivated whole cell Coxiella burnetii vaccine (Henzerling strain, Ph ase 1 [Q-Vax, CSL]) in the prevention of Q fever among abattoir worker s. Design and setting: The study was a retrospective cohort survey of all employees at three South Australian abattoirs to determine the inc idence of Q fever among vaccinated and unvaccinated employees during t he period 1985 to 1990. Results: There were two cases of Q fever among 2555 vaccinated employees of the three abattoirs, compared with 55 ca ses among 1365 unvaccinated employees. The two Q fever cases in vaccin ated employees were within a few days of vaccination, before immunity had developed, and represented a coincidence of natural infection and vaccination. Protective efficacy was 100%, even with a batch of Q-Vax containing 20 mu g/dose rather than the standard dose of 30 mu g/dose. Conclusions: Vaccination was effective for at least five years, altho ugh it was uncertain whether this was due to the vaccine per se or to a combination of vaccine immunity reinforced by periodic natural expos ure.